| Application no. and date | 17722943.2 (espacenet) (Federated) (European Patent Register), 20170426 | | Patent/reg. no. and date | DK/EP 3463328, 20220615 | | Publication date | 20190410 | | Priority no. and date | US 201662343688 P, 20160531 | | EP pub. no. and date |
EP 3463328 20190410 | | Effective date | | | Applicant/owner | CymaBay Therapeutics, Inc., 7575 Gateway Boulevard, Suite 110
Newark, CA 94560, US | | Applicant ref. no. | V444635DK00 | | Inventor | BOUDES, Pol, c/o CymaBay Therapeutics, Inc.
7575 Gateway Boulevard
Suite 110
Newark, CA 94560, US,
MCWHERTER, Charles, A., c/o CymaBay Therapeutics, Inc.
7575 Gateway Boulevard
Suite 110
Newark, CA 94560, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/192 (2006.01) , A61P 1/16 (2006.01) | | Title | Seladelpar til behandling af primær biliær cholangitis | | Int. application no. | US2017029620 | | Int. publication no. | WO2017209865 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
